References
- Miserocchi E, Fogliato G, Modorati G, et al. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. 2013;23(5):705–717. doi:https://doi.org/10.5301/ejo.5000278.
- Maca SM, Schiesser AW, Sobala A, et al. Distress, depression and coping in HLA-B27-associated anterior uveitis with focus on gender differences. Brit J Ophthalmol. 2011;95(5):699–704. doi:https://doi.org/10.1136/bjo.2009.174839.
- Smet MDD, Taylor SRJ, Bodaghi B, et al. Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res. 2011;30(6):452–470. doi:https://doi.org/10.1016/j.preteyeres.2011.06.005.
- Hu S, Xie C, Yang P, et al. An epidemiological survey of uveitis in southern China. US Chin J Ophthalmol. 2002;2(1):1–3.
- Hwang DK, Chou YJ, Pu CY, et al. Epidemiology of uveitis among the Chinese population in Taiwan. Ophthalmology. 2012;119(11):2371–2376. doi:https://doi.org/10.1016/j.ophtha.2012.05.026.
- Maca SM, Julia W, Birgit W, et al. Acute anterior uveitis is associated with depression and reduction of general health. Brit J Ophthalmol. 2013;97(3):333–337. doi:https://doi.org/10.1136/bjophthalmol-2012-302304.
- Hui MM, Wakefield D, Patel I, et al. Visual functioning and health-related quality-of-life are compromised in patients with uveitis. Ocul Immunol Inflamm. 2017;25(4):486–491. doi:https://doi.org/10.3109/09273948.2016.1139734.
- Berlinberg EJ, Gonzales JA, Doan T, et al. Association between noninfectious uveitis and psychological stress. JAMA Ophthalmol. 2019;137(2):199–205. doi:https://doi.org/10.1001/jamaophthalmol.2018.5893.
- Onal S, Oray M, Yasa C, et al. Screening for depression and anxiety in patients with active uveitis. Ocul Immunol Inflamm. 2018;26(7):1078–1093. doi:https://doi.org/10.1080/09273948.2017.1319959.
- Arias-de la Torre J, Vilagut G, Martín V, et al. Prevalence of major depressive disorder and association with personal and socio-economic factors. Results for Spain of the European health interview survey 2014-2015. J Affect Disorders. 2018;239:203–207. doi:https://doi.org/10.1016/j.jad.2018.06.051.
- Lorant V, Deliège D, Eaton W, et al. Socioeconomic inequalities in depression: A meta-analysis. Am J Epidemiol. 2003;157(2):98–112. doi:https://doi.org/10.1093/aje/kwf182.
- Evans JR, Fletcher AE, Wormald RP. Depression and anxiety in visually impaired older people. Ophthalmology. 2007;114(2):283–288. doi:https://doi.org/10.1016/j.ophtha.2006.10.006.
- Adamson BC, Yang Y, Motl RW. Association between compliance with physical activity guidelines, sedentary behavior and depressive symptoms. Prev Med. 2016;91:152–157. doi:https://doi.org/10.1016/j.ypmed.2016.08.020.
- Zhu Y, Wu Z, Sie O, et al. Causes of drug discontinuation in patients with major depressive disorder in China. Prog Neuro-psychoph. 2019;96:109755. doi:https://doi.org/10.1016/j.pnpbp.2019.109755.
- Chaumet-Riffaud AE, Chaumet-Riffaud P, Cariou A, et al. Impact of retinitis pigmentosa on quality of life, mental health, and employment among young adults. Am J Ophthalmol. 2017;177:169–174. doi:https://doi.org/10.1016/j.ajo.2017.02.016.
- Elshout M, Van Der Reis MI, De J-H Y, et al. Distinguishing between better and worse visual acuity by studying the correlation with quality of life in neovascular age-related macular degeneration. Ophthalmology. 2016;123(11):2408–2412. doi:https://doi.org/10.1016/j.ophtha.2016.07.015.
- Zhang X, Olson DJ, Le P, et al. The association between glaucoma, anxiety, and depression in a large population. Am J Ophthalmol. 2017;183:37–41. doi:https://doi.org/10.1016/j.ajo.2017.07.021.
- Diniz-Filho A, Abe RY, Cho HJ, et al. Fast visual field progression is associated with depressive symptoms in patients with glaucoma. Ophthalmology. 2016;123(4):754–759. doi:https://doi.org/10.1016/j.ophtha.2015.12.014.
- Sugar EA, Venugopal V, Thorne JE, et al. Longitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapy. Ophthalmology. 2017;124(11):1662–1669. doi:https://doi.org/10.1016/j.ophtha.2017.05.015.
- Niemeyer KM, Gonzales JA, Rathinam SR, et al. Quality of life outcomes from a randomized clinical trial comparing antimetabolites for intermediate, posterior, and panuveitis. Am J Ophthalmol. 2017;179:10–17. doi:https://doi.org/10.1016/j.ajo.2017.04.003.
- Sheppard J, Joshi A, Betts KA, et al. Effect of adalimumab on visual functioning in patients with noninfectious intermediate uveitis, posterior uveitis, and panuveitis in the visual-1 and visual-2 trials. JAMA Ophthalmol. 2017;135(6):511–518. doi:https://doi.org/10.1001/jamaophthalmol.2017.0603.
- Barron BA, Gee L, Hauck WW, et al. Herpetic eye disease study: A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1871–1882. doi:https://doi.org/10.1016/S0161-6420(13)31155-5.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Nussenblatt RB, Palestine AG, Chan CC, et al. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471. doi:https://doi.org/10.1016/S0161-6420(85)34001-0.
- Jiang JH, Zhang SD, Dai ML, et al. Posner-Schlossman syndrome in Wenzhou, China: A retrospective review study. Brit J Ophthalmol. 2017;101(12):1638–1642. doi:https://doi.org/10.1136/bjophthalmol-2016-309863.
- Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi:https://doi.org/10.1038/nrn2297.
- Pucak ML, Kaplin AI. Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression. Int Rev Psychiatry. 2005;17(6):477–483. doi:https://doi.org/10.1080/02646830500381757.
- Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacol. 2012;37(1):137–162. doi:https://doi.org/10.1038/npp.2011.205.
- Fu X, Zunich SM, O’Connor JC, et al. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation. 2010;7(1):43. doi:https://doi.org/10.1186/1742-2094-7-43.
- Darin-Mattsson A, Andel R, Celeste RK, et al. Linking financial hardship throughout the life-course with psychological distress in old age: sensitive period, accumulation of risks, and chain of risks hypotheses. Soc Sci Med. 2018;201:111–119. doi:https://doi.org/10.1016/j.socscimed.2018.02.012.
- Bjelland I, Krokstad S, Mykletun A, et al. Does a higher educational level protect against anxiety and depression? The hunt study. Soc Sci Med. 2008;66(6):1334–1345. doi:https://doi.org/10.1016/j.socscimed.2007.12.019.
- Uutela A. Economic crisis and mental health. Current Opinion in Psychiatry. 2010;23(2):127–130. doi:https://doi.org/10.1097/YCO.0b013e328336657d.
- Liu S, Griffiths SM. From economic development to public health improvement: china faces equity challenges. Public Health. 2011;125(10):669–674. doi:https://doi.org/10.1016/j.puhe.2011.08.004.
- Plskova J, Greiner K, Forrester JV. Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis. Am J Ophthalmol. 2007;144(1):55–61. doi:https://doi.org/10.1016/j.ajo.2007.03.050.
- Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor-alpha antagonist infliximab in treatment resistant depression: role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31–41. doi:https://doi.org/10.1001/2013.jamapsychiatry.4.
- Nerurkar L, Siebert S, McInnes IB, et al. Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiatry. 2019;6(2):164–173. doi:https://doi.org/10.1016/S2215-0366(18)30255-4.
- Qian Y, Glaser T, Esterberg E, et al. Depression and visual functioning in patients with ocular inflammatory disease. Am J Ophthalmol. 2012;153(2):370–378. doi:https://doi.org/10.1016/j.ajo.2011.06.028.
- Wang H, Sun HP, Wang P, et al. Cataract and depressive symptoms among older Chinese adults. Optometry Vision Sci. 2016;93(12):1479–1484. doi:https://doi.org/10.1097/OPX.0000000000000960.
- Safiri S, Ayubi E. Depressive symptoms in older adults awaiting cataract surgery: methodological and statistical issues. Clin Exp Ophthalmol. 2017;45(8):840–841. doi:https://doi.org/10.1111/ceo.12970.
- Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: A population-based study of 662 adults. Front Aging Neurosci. 2013;5(11):56. doi:https://doi.org/10.3389/fnagi.2013.00056.
- Ishii K, Kabata T, Oshika T. The impact of cataract surgery on cognitive impairment and depressive mental status in elderly patients. Am J Ophthalmol. 2008;146(3):404–409. doi:https://doi.org/10.1016/j.ajo.2008.05.014.
- Accorinti M, Okada AA, Smith JR, et al. Epidemiology of macular edema in uveitis. Ocul Immunol Inflamm. 2019;27(2):169–180. doi:https://doi.org/10.1080/09273948.2019.1576910.
- Rees G, Xie J, Fenwick EK, et al. Association between diabetes-related eye complications and symptoms of anxiety and depression. JAMA Ophthalmol. 2016;134(9):1007–1014. doi:https://doi.org/10.1001/jamaophthalmol.2016.2213.
- Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of life and risks associated with systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, or panuveitis: fifty-four-month results of the multicenter uveitis steroid treatment trial and follow-up study. Ophthalmology. 2015;122(10):1976–1986. doi:https://doi.org/10.1016/j.ophtha.2015.06.043.
- Court H, Mclean G, Guthrie B, et al. Visual impairment is associated with physical and mental comorbidities in older adults: A cross-sectional study. BMC Med. 2014;12(1):181. doi:https://doi.org/10.1186/s12916-014-0181-7.
- Arriola-Villalobos P, Abásolo L, García-Feijoo J, et al. Vision-related quality of life in patients with non-infectious uveitis: A cross-sectional study. Ocul Immunol Inflamm. 2018;26(5):717–725. doi:https://doi.org/10.1080/09273948.2017.1285034.
- Torrance GW. Preferences for health states: A review of measurement methods. Mead Johnson Symp Perinat Dev Med. 1982;20:37–45.
- Shamdas M, Bassilious K, Murray PI. Health-related quality of life in patients with uveitis. Brit J Ophthalmol. 2019;103(9):1284–1288. doi:https://doi.org/10.1136/bjophthalmol-2018-312882.
- Tengs TO, Lin TH. A meta-analysis of utility estimates for HIV/AIDS. Med Decis Making. 2002;22(6):475–481. doi:https://doi.org/10.1177/0272989X02238300.
- García-Molina M, Chicaiza-Becerra LA. Anchoring bias in face-to-face time-trade-off valuations of health states. Rev Salud Publica (Bogota). 2017;19(5):686–690. doi:https://doi.org/10.15446/rsap.v19n5.60924.
- Turan O, Yemez B, Itil O. The effects of anxiety and depression symptoms on treatment adherence in COPD patients. Prim Health Care Res Dev. 2014;15(3):244–251. doi:https://doi.org/10.1017/S1463423613000169.
- Sittivarakul W, Wongkot P. Anxiety and depression among patients with uveitis and ocular inflammatory disease at a tertiary center in southern Thailand: vision-related quality-of-life, sociodemographics, and clinical characteristics associated. Ocul Immunol Inflamm. 2019;27(5):731–742. doi:https://doi.org/10.1080/09273948.2018.1484495.
- Kong XM, Zhu WQ, Hong JX, et al. Is glaucoma comprehension associated with psychological disturbance and vision-related quality of life for patients with glaucoma? A cross-sectional study. BMJ Open. 2014;4(5):e004632. doi:https://doi.org/10.1136/bmjopen-2013-004632.